This inventor holds 4 USPTO granted patents. Top assignee: Research, Incorporated. Active years: 1984-1991.
Company Filing History:
Years Active: 1984-1991
Title: Randy W. Johnson: Innovator in Platelet Aggregation Inhibition
Introduction
Randy W. Johnson is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of medical science, particularly in the development of agents that inhibit platelet aggregation. With a total of 4 patents to his name, Johnson's work has the potential to impact treatments for various cardiovascular conditions.
Latest Patents
Among his latest patents, Johnson has developed innovative compounds such as N,N'-bis(nipecotyl)piperazines, which serve as platelet aggregation inhibitory agents. This invention focuses on the use of these compounds to prevent blood platelet aggregation, a crucial factor in cardiovascular health. Additionally, he has worked on tetrahydroquinoline derivatives, which also aim to inhibit blood platelet aggregation, showcasing his commitment to advancing medical treatments.
Career Highlights
Randy W. Johnson is currently associated with Research, Incorporated, where he continues to explore and develop new therapeutic agents. His work is characterized by a strong emphasis on research and innovation, contributing to the advancement of medical science.
Collaborations
Throughout his career, Johnson has collaborated with notable colleagues, including Ronald P. Quintana and Andrew Lasslo. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Randy W. Johnson's contributions to the field of platelet aggregation inhibition highlight his innovative spirit and dedication to improving medical treatments. His patents and ongoing research continue to pave the way for advancements in cardiovascular health.